title: Budget Impact and Incremental Survival Benefit of Eribulin Mesylate as a Treatment for Metastatic Breast Cancer in Brazil.
authors.affiliation: Eisai, Woodcliff Lake, NJ, USA.
authors.forename: U
authors.initials: U
authors.lastname: Majethia
authors.affiliation: Eisai Inc, Woodcliff Lake, NJ, USA.
authors.forename: G
authors.initials: G
authors.lastname: Tremblay
authors.affiliation: Evidências, Campinas, Brazil.
authors.forename: L
authors.initials: L
authors.lastname: Borges
authors.affiliation: Eisai, Woodcliff Lake, NJ, USA.
authors.forename: T
authors.initials: T
authors.lastname: Jones
authors.affiliation: Eisai Inc, Woodcliff Lake, NJ, USA.
authors.forename: A
authors.initials: A
authors.lastname: Forsythe
authors.affiliation: Kantar Health, Princeton, NJ, USA.
authors.forename: D
authors.initials: D
authors.lastname: Pomerantz
authors.affiliation: Evidencias, Campinas, Brazil.
authors.forename: O A C
authors.initials: OA
authors.lastname: Clark